ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    The Impact of Sequential Gene Modifications on Cardiac Xenograft Survival.

    K. Horvath,1 A. Singh,1 J. Chan,1 M. Thomas,2 B. Lewis,2 D. Ayares,3 P. Corcoran,1 M. Mohiuddin.1

    1CSRP, NHLBI/NIH, Bethesda, MD; 2DVR / ORS, NIH, Bethesda, MD; 3Revivicor, Inc, Blacksburg, VA.

    Introduction: One of the major advances in xenotransplantation is the ability to modify donor pig genetics. Using rapidly evolving techniques of pig cloning and gene…
  • 2016 American Transplant Congress

    IL-17-Producing CCR6+CD4+ Th17 Cells Drive Intestinal Allograft Rejection in Humans.

    J. Kaiser, C. Cosentino, A. Shukla, C. Desai, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.

    MedStar Georgetown Transplant Institute, Washington DC.

    A. Allograft rejection remains a significant source of mortality and morbidity in intestinal transplant (ITx) recipients. However, the underlying mechanisms remain unclear. The purpose of…
  • 2016 American Transplant Congress

    Outcomes of Solid Organ Transplant Recipients with Pre-Existing Malignancies.

    S. Acuna,1,2,3 R. Sutradhar,1,2 J. Kim,1,2,4 N. Baxter.1,2,3

    1Institute of Health Policy, Management and Education, University of Toronto, Toronto, ON, Canada; 2Institute of Clinical Evaluative Sciences, Toronto, ON, Canada; 3Department of Surgery, St. Michael's Hospital, Toronto, ON, Canada; 4Department of Medicine, University Health Network, Toronto, ON, Canada.

    Background: Pre-transplant malignancy (PTM) is considered a relative contraindication for transplantation due to the heightened risk of cancer recurrence associated with immunosuppression. However, little has…
  • 2016 American Transplant Congress

    Live Donor Liver Transplantation for NASH: The Toronto Experience.

    A. Barbas, N. Goldaracena, M. Dib, M. Marquez, G. Sapisochin, D. Al-Adra, I. McGilvray, M. Cattral, P. Greig, D. Grant.

    General Surgery, Multi-Organ Transplant, University of Toronto, Toronto, ON, Canada.

    Background:Non-alcoholic steatohepatitis (NASH) is an increasingly common indication for liver transplantation in North America. In the context of organ scarcity and significant waitlist mortality, our…
  • 2016 American Transplant Congress

    BK Nephropathy, but Not Isolated BK Viremia Associated with De Novo DSA Despite Similar Immunosuppression Reduction.

    W. Cheungpasitporn,1 D. Mitema,1 H. Amer,1 F. Cosio,1 M. Stegall,2 C. Schinstock.1

    1Nephrology and Hypertension, Mayo Clinic, Rochester, MN; 2Transplantation Surgery, Mayo Clinic, Rochester, MN.

    Introduction: Reduced immunosuppression is associated with de novo DSA (dn DSA). Although immunosuppression is often reduced in patients with polyomavirus (BK), the incidence of dn…
  • 2016 American Transplant Congress

    Acute Kidney Injury and Chronic Kidney Disease in Donation After Circulatory Death Liver Transplantation: UK Single Centre Study.

    I. Umbro,1,2 F. Tinti,1,2 F. Evison,3 A. Sharif,4 B. Gunson,5 A. Mitterhofer,2 J. Ferguson,1 P. Muiesan.1

    1The Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom; 2Nephrology and Dialysis Unit, Sapienza University of Rome, Rome, Italy; 3Department of Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom; 4Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, United Kingdom; 5NIHR Birmingham Liver Biomedical Research Unit and Centre for Liver Research, University of Birmingham, Birmingham, United Kingdom.

    Aim of the study is to assess the incidence of acute kidney injury (AKI) and chronic kidney disease (CKD) after liver transplantation (LT) in DCD…
  • 2016 American Transplant Congress

    Pharmacist Impact on Medication Errors in a Chronic Kidney Transplant Clinic.

    K. Covert,1 C. Mardis,1 J. Fleming,1 A. Mardis,1 H. Meadows,1 N. Pilch,1 P. Mohan,2 M. Posadas,2 M. Salazar,2 T. Srinivas,2 G. Mour,2 D. Taber.1

    1Pharmacy, The Medical University of South Carolina, Charleston, SC; 2Transplant Nephrology, The Medical University of South Carolina, Charleston, South Carolina.

    Medication errors are associated with increased incidence of infection, rejection, and graft loss in kidney transplant recipients. This study aims to assess the impact of…
  • 2016 American Transplant Congress

    Morbid Obesity and Functional Status as Predictors of Surgical Complication After Renal Transplantation.

    T. Veasey, J. Fleming, S. Strout, R. Miller, N. Pilch, H. Meadows, C. Mardis, B. Mardis, P. Baliga, J. McGillicuddy, D. Taber.

    Medical University of South Carolina, Charleston, SC.

    Purpose: Surgical complications after renal transplant may impact patient morbidity and healthcare utilization. Identification of patients at risk would allow for planning allocation of resources…
  • 2016 American Transplant Congress

    The Influence of Rising Lab MELD on Vascular Invasion in HCC.

    K. Halazun, E. Przybyszewski, E. Verna, B. Samstein, A. Fox, R. Brown, J. Emond.

    Liver Transplant & HPB Surgery, Weill Cornell Medical College, NY, NY.

    Background Vascular invasion (VI) is one of the most important predictors of HCC recurrence. Although attempts to identify predictors of VI have been made, datasets…
  • 2016 American Transplant Congress

    Anti-Angiotensin II Type 1 Receptor Antibody Reduction with Proteasome Inhibitor-Based Desensitization.

    A. Girnita, E. Portwood, P. Brailey, S. Tremblay, R. Alloway, E. Woodle.

    University of Cincinnati, Cincinnati.

    Background. Desensitization results have largely focused on effects on anti-HLA antibody (HLA-Ab) and anti-ABO antibody levels. Anti-angiotensin II type 1 receptor antibody (AT1R-Ab) has recently…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences